Quantcast

Latest Percodan Stories

2009-05-07 15:05:00

CHADDS FORD, Pa., May 7 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) announced today the appointment of Alan G. Levin as the company's executive vice president and chief financial officer, effective June 1, 2009. Previously, Mr.

2009-05-06 07:30:00

CHADDS FORD, Pa., May 6 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) announced today that it will present at the Bank of America and Merrill Lynch 2009 Health Care Conference on Wednesday, May 13, 2009 at 12:40 pm Eastern Time.

2009-04-08 15:40:00

CHADDS FORD, Pa., April 8 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) will announce its first quarter financial results on April 29, 2009 and will host a conference call and webcast at 10:30 a.m. ET that day to discuss these results. David P.

2009-03-23 15:34:00

CHADDS FORD, Pa., March 23 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced the successful completion of its acquisition of Indevus Pharmaceuticals, Inc.

2009-03-19 07:55:00

CHADDS FORD, Pa., March 19 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced the successful completion of the tender offer by its wholly owned subsidiary, BTB Purchaser Inc., for all of the outstanding shares of common stock of Indevus Pharmaceuticals, Inc.

2009-02-27 06:29:00

CHADDS FORD, Pa., Feb. 27 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) announced today that it has licensed from Grunenthal the exclusive rights to develop and market the investigational drug axomadol in the United States and Canada.

2009-02-26 07:30:00

CHADDS FORD, Pa., Feb. 26 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) announced today the appointment of William P. Montague to the company's board of directors. Mr. Montague, 62, who was chief executive officer and a director of Mark IV Industries, retired in July last year.

2009-02-10 15:30:00

CHADDS FORD, Pa., Feb. 10 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) announced today that it has signed two research collaboration agreements to develop novel treatments for pain and to discover potential treatments for cancer.

2009-01-29 15:07:00

CHADDS FORD, Pa., Jan. 29 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) announced today that by mutual agreement it has concluded its research collaboration with Alexza Pharmaceuticals, Inc.

2009-01-28 15:30:00

CHADDS FORD, Pa., Jan. 28 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals Inc. (Nasdaq: ENDP), will announce its fourth quarter and 2008 full-year financial results on February 27, 2009 and will host a conference call and webcast at 10:30 a.m. ET that day to discuss these results. David P.


Word of the Day
adustion
  • The act of burning, scorching, or heating to dryness; the state or being thus heated or dried.
  • In medicine, cauterization.
The word 'adustion' comes from the Latin 'adustio', 'burning'.
Related